Literature DB >> 24905201

Protein kinase R and the inflammasome.

Howard C H Yim1, Bryan R G Williams.   

Abstract

Protein kinase R (PKR) was first identified as a mediator of the double-stranded RNA (dsRNA)-mediated inhibition of protein synthesis in extracts from interferon-treated cells. In a physiological context, viral replication results in production of dsRNA, activation of PKR by autophosphorylation, and phosphorylation of the protein synthesis initiation factor eIF2α. Subsequent biochemical, structural, and genetic analyses have identified the dsRNA and kinase domain structure of PKR, and shown that its deletion from the germline of mice results in impaired resistance to infection by many different viruses. These studies have also opened up roles for PKR in different signaling pathways, the most recent being regulation of the inflammasome. Here we review evidence for this newly ascribed function for PKR and discuss roles in inflammasome regulation and associated diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24905201     DOI: 10.1089/jir.2014.0008

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  20 in total

1.  TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes.

Authors:  Thomas J LaRocca; Andrea Mariani; Linda R Watkins; Christopher D Link
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

2.  RNase L activates the NLRP3 inflammasome during viral infections.

Authors:  Arindam Chakrabarti; Shuvojit Banerjee; Luigi Franchi; Yueh-Ming Loo; Michael Gale; Gabriel Núñez; Robert H Silverman
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

Review 3.  Disease of mRNA Regulation: Relevance for Ischemic Brain Injury.

Authors:  Donald J DeGracia
Journal:  Transl Stroke Res       Date:  2017-11-10       Impact factor: 6.829

4.  Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3.

Authors:  M A G Rabbani; Michael Ribaudo; Ju-Tao Guo; Sailen Barik
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

5.  Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.

Authors:  Kristina L Schierhorn; Fabian Jolmes; Julia Bespalowa; Sandra Saenger; Christin Peteranderl; Julia Dzieciolowski; Maja Mielke; Matthias Budt; Stephan Pleschka; Andreas Herrmann; Susanne Herold; Thorsten Wolff
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

6.  Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells.

Authors:  Lili Gao; Wei Tang; ZhengZheng Ding; DingYu Wang; XiaoQiang Qi; HuiWen Wu; Jun Guo
Journal:  Mol Med       Date:  2015-02-18       Impact factor: 6.354

7.  Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation.

Authors:  Anne-Sophie Carret-Rebillat; Clarisse Pace; Sarah Gourmaud; Laura Ravasi; Samantha Montagne-Stora; Sophie Longueville; Marion Tible; Erika Sudol; Raymond Chuen-Chung Chang; Claire Paquet; François Mouton-Liger; Jacques Hugon
Journal:  Sci Rep       Date:  2015-02-17       Impact factor: 4.379

8.  p58(IPK) suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages.

Authors:  Evgenii Boriushkin; Joshua J Wang; Junhua Li; Maulasri Bhatta; Sarah X Zhang
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

9.  NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.

Authors:  Markus Kainulainen; Simone Lau; Charles E Samuel; Veit Hornung; Friedemann Weber
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

10.  HIV-1 Tat protein enhances the intracellular growth of Leishmania amazonensis via the ds-RNA induced protein PKR.

Authors:  Áislan de Carvalho Vivarini; Renata de Meirelles Santos Pereira; Victor Barreto-de-Souza; Jairo Ramos Temerozo; Deivid C Soares; Elvira M Saraiva; Alessandra Mattos Saliba; Dumith Chequer Bou-Habib; Ulisses Gazos Lopes
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.